Prognostic value of C-reactive protein in parapneumonic effusions

Respirology

Volumn 17, Issue 2, 2012, Pages 308-314

  Skouras, Vasileios ^a   Boultadakis, Euaggelos ^b   Nikoulis, Dimitrios ^c   Polychronopoulos, Vlasis ^e   Daniil, Zoe ^d   Kalomenidis, Ioannis ^f   Gourgoulianis, Konstantinos I ^d  

^a 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

^b Tzaneio General Hospital   (Greece)

^c Immunology Department   (Greece)

^d UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^e KAT HOSPITAL   (Greece)

^f UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

C reactive protein; complicated parapneumonic effusion; drainage; pleural infection; residual pleural thickening

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE;

ADULT; AGED; ARTICLE; COMPLICATED PARAPNEUMONIC EFFUSION; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PLEURA FLUID; PLEURA THICKENING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIAGNOSIS, DIFFERENTIAL; EXUDATES AND TRANSUDATES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84856275034     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.02078.x     Document Type: Article

References (27)

1. Light RW,. Parapneumonic effusions and empyema. In:, Light RW, (ed.) Pleural Diseases. Lippincott Williams & Wilkins, Philadelphia, PA, 2007; 179-210.
2. Halm EA, Teirstein AS,. Clinical practice. Management of community-acquired pneumonia. N. Engl. J. Med. 2002; 347: 2039-45. (Pubitemid 35461661)
3. Jimenez Castro D, Diaz G, Perez-Rodriguez E, et al,. Prognostic features of residual pleural thickening in parapneumonic pleural effusions. Eur. Respir. J. 2003; 21: 952-5. (Pubitemid 36675609)
4. Colice GL, Curtis A, Deslauriers J, et al,. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000; 118: 1158-71.
5. Skouras V, Awdankiewicz A, Light RW,. What size parapneumonic effusions should be sampled? Thorax 2010; 65: 91.
6. Davies HE, Davies RJ, Davies CW,. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65: 41-53.
7. Kalomenidis I, Bouros D,. Pleural fluid pH in parapneumonic pleural effusions: drawing the line. Respiration 2005; 72: 345-6. (Pubitemid 41160163)
8. Rahman NM, Mishra EK, Davies HE, et al,. Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose. Am. J. Respir. Crit. Care Med. 2008; 178: 483-90.
9. Papaioannou AI, Kostikas K, Tsopa P, et al,. Residual pleural thickening is related to vascular endothelial growth factor levels in parapneumonic pleural effusions. Respiration 2010; 80: 472-9.
10. Castano Vidriales JL, Amores Antequera C,. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions. Eur. J. Med. 1992; 1: 201-7.
11. Agapakis DI, Tsantilas D, Psarris P, et al,. Coagulation and inflammation biomarkers may help predict the severity of community-acquired pneumonia. Respirology 2010; 15: 796-803.
12. Chalmers JD, Singanayagam A, Hill AT,. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am. J. Med. 2008; 121: 219-25. (Pubitemid 351317927)
13. Kiropoulos TS, Kostikas K, Oikonomidi S, et al,. Acute phase markers for the differentiation of infectious and malignant pleural effusions. Respir. Med. 2007; 101: 910-18. (Pubitemid 46505997)
14. Porcel JM, Galindo C, Esquerda A, et al,. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions. Respirology 2008; 13: 58-62.
15. Porcel JM, Vives M, Cao G, et al,. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur. Respir. J. 2009; 34: 1383-9.
16. Rossi VF, Vargas FS, Marchi E, et al,. Acute inflammatory response secondary to intrapleural administration of two types of talc. Eur. Respir. J. 2010; 35: 396-401.
17. Boultadakis V, Skouras V, Makris D, et al,. Serum amyloid alpha in parapneumonic effusions. Mediators Inflamm. 2011; doi: 237638.2011
18. Mandell LA, Wunderink RG, Anzueto A, et al,. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44: 27-72.
19. Niederman MS, Craven DE, on behalf of the American Thoracic Society and the Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 2005; 171: 388-416.
20. Dellinger RP, Levy MM, Carlet JM, et al,. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med. 2008; 36: 296-327.
21. de Pablo A, Villena V, Echave-Sustaeta J, et al,. Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis? Chest 1997; 112: 1293-7. (Pubitemid 27497862)
22. Candela A, Andujar J, Hernandez L, et al,. Functional sequelae of tuberculous pleurisy in patients correctly treated. Chest 2003; 123: 1996-2000. (Pubitemid 36706724)
23. Nagayama N, Tamura A, Kurashima A, et al,. Parameters relating to the development of residual pleural thickening in tuberculous pleurisy. Kekkaku 1999; 74: 91-7. (Pubitemid 29127956)
24. Kim A, Capitano B, Nightingale CH,. Pleural pharmacokinetics. In:, Light RW, Lee YCG, (eds) Textbook of Pleural Diseases. Hodder Arnold, London, 2008; 151-68.
25. Maskell NA, Batt S, Hedley EL, et al,. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am. J. Respir. Crit. Care Med. 2006; 174: 817-23. (Pubitemid 44511664)
26. Jimenez Castro D, Diaz Nuevo G, Sueiro A, et al,. Pleural fluid parameters identifying complicated parapneumonic effusions. Respiration 2005; 72: 357-64. (Pubitemid 41160167)
27. Chen SC, Chen W, Hsu WH, et al,. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema. Lung 2006; 184: 141-5. (Pubitemid 44222461)